U.S. Markets open in 4 hrs 13 mins

Champagne Remark May Cost Lawyer $289 Million Bayer Award

Joel Rosenblatt
Champagne Remark May Cost Lawyer $289 Million Bayer Award

(Bloomberg) -- The lawyer most responsible for winning a $289 million verdict against Bayer AG may end up wiping it out.

Brent Wisner was the lead trial attorney who in August convinced a jury that Monsanto Co.’s Roundup weed killer caused his client’s cancer. His compelling arguments and marshaling of evidence resulted in a blockbuster verdict that has spooked investors looking ahead to thousands of similar lawsuits across the U.S. pending against Monsanto, which Bayer acquired in June.

But Wisner’s closing arguments at trial irked the judge handling the case so profoundly that she’s considering tossing the verdict and ordering a new trial. The lawyer told jurors that Monsanto executives in a company board room were "waiting for the phone to ring" and that "behind them is a bunch of champagne on ice," according to a court filing. He said that “if the damages number isn’t significant enough, champagne corks will pop.”

At a hearing Wednesday, San Francisco Judge Suzanne Ramos Bolanos cited a number of reasons why she’s inclined to set aside or dramatically cut the verdict. But she singled out the champagne comment as she questioned whether Wisner’s impassioned rhetoric crossed a line. Wisner also told jurors their decision could “change the world” and they could become a “part of history.” Bolanos said the comments may prove “sufficiently prejudicial” to warrant a new trial.

What’s Next in Court for Bayer Crop-Chemical Claims: QuickTake

The judge reminded Wisner, who joined the hearing by telephone, that she took him aside during the trial’s closing arguments and warned him about his champagne comments. “In front of the jury you disregarded my order, and again repeated the same objectionable statement,” she said.

Bolanos was incredulous when Wisner seemed to suggest that he wasn’t aware of the objection to the champagne reference in particular.

“We believe there was more than adequate evidence provided to this attentive, highly educated jury supporting each of their findings,” Baum Hedlund Aristei & Goldman PC, Wisner’s law firm, said in a statement. “It will be up to the court of appeals to review the evidence and this unanimous jury’s findings in a light most favorable to Lee Johnson.”

Video: Monsanto Ordered to Pay $289 Million in Roundup Cancer Trial

For more news videos visit Yahoo View .

Last year, a federal judge in San Francisco handling hundreds of Roundup lawsuits against Monsanto threatened to remove Wisner or his firm from the massive litigation because the lawyer made headlines when he publicly released company emails that his firm said demonstrated manipulation of public opinion about Roundup’s health risks.

‘PR Man’

Wisner "was not focused on being a lawyer, he was focused on being a PR man," U.S. District Judge Vince Chhabria said at a hearing. "He was more focused in getting these documents released, and getting them released fast, than he was in being a lawyer.”

Monsanto’s lawyer, George Lombardi, told Bolanos the champagne comment “was thumbing his nose” at the judge. “Think of the image that creates,” he said. “It was objected to, it was not factual. It is punishing Monsanto for having a board member, it’s punishing Monsanto for being a big company.”

By the end of the hearing Bolanos said she was considering options including setting aside the punitive damages of $250 million, whittling down the compensatory damages from $33 million to about $9 million, and ordering a new trial. American depositary shares of Leverkusen, Germany-based Bayer jumped 6.3 percent Wednesday to close at $79.50 in New York.

The judge is examining the company’s arguments that there no basis for the jury to conclude that Monsanto is liable for plaintiff Lee Johnson’s non-Hodgkin lymphoma based on his exposure to the key ingredient in Roundup, glyphosate.

Lombardi said the medical evidence at trial was “legally insufficient” to prove exposure to Roundup caused Johnson’s disease. He argued that the diagnosis provided by the plaintiff’s medical expert was “extraordinarily simplistic and deceptive.”

Michael Miller, a lawyer for Johnson, told Bolanos that there’s “not a scintilla of evidence” that the “well-educated, very attentive, note-taking” jury didn’t follow the judge’s instructions.

While Miller acknowledged that the plaintiff might have lost if the case was decided by Bolanos, he said there was no error that justifies “taking away a verdict of a dying man.”

The case is Dewayne Johnson v. Monsanto Co., CGC-16-550128, California Superior Court, County of San Francisco (San Francisco).

(Updates with statement from lawyer’s firm in seventh paragraph.)

To contact the reporter on this story: Joel Rosenblatt in San Francisco at jrosenblatt@bloomberg.net

To contact the editors responsible for this story: Elizabeth Wollman at ewollman@bloomberg.net, Peter Blumberg

For more articles like this, please visit us at bloomberg.com

©2018 Bloomberg L.P.

  • Finance
    CNBC

    Morgan Stanley: The stock sell-off is going to get worse

    The stock market is in the middle of a rolling bear market, says Morgan Stanley's Mike Wilson. "It's being caused by a drain in liquidity and peaking growth," Wilson says. The stock market sell-off is only going to get worse, predicts Morgan Stanley's chief U.S. equity strategist, Mike Wilson.

  • These are the bad things about early retirement that no one talks about
    News
    MarketWatch

    These are the bad things about early retirement that no one talks about

    For all the glamour of living an early retirement lifestyle, there are plenty of negatives I’ve come to discover since I permanently left my job in 2012. As a result, you’re repeatedly forced to will yourself into action.

  • Why Marijuana Stocks Cronos Group, Canopy Growth, and Tilray Jumped Today
    Business
    Motley Fool

    Why Marijuana Stocks Cronos Group, Canopy Growth, and Tilray Jumped Today

    The stock market pulled back on Monday, with major benchmarks failing to build on the positive momentum from last Friday. Cronos Group (NASDAQ: CRON), Canopy Growth (NYSE: CGC), and Tilray (NASDAQ: TLRY) were among the best performers. All three of these stocks have something in common: They all stand to benefit from Wednesday's effective date for legal sales of recreational cannabis product in Canada.

  • Brits Are All Making the Same Joke About the New Royal Baby
    News
    Time

    Brits Are All Making the Same Joke About the New Royal Baby

    Meghan Markle, the Duchess of Sussex, is expecting her first child with Prince Harry. The news, announced Monday morning by Kensington Palace, has already been greeted by hundreds of messages of congratulations for the royal couple on social media. The U.K. is set to leave the European Union on March 29, exactly two years after Prime Minister Theresa May started the formal process for doing so by invoking Article 50 of the Lisbon Treaty.

  • Sears bankruptcy could make these 5 big companies multi-million-dollar losers
    Finance
    Yahoo Finance

    Sears bankruptcy could make these 5 big companies multi-million-dollar losers

    Being an unsecured creditor of Sears (SHLD) right now is not a good place to be. The 125-year old former retail icon filed for chapter 11 bankruptcy protection early on Monday, crippled from years of losses and mounting debt. Sears plans to close about

  • Elizabeth Warren Calls on Trump to Pay $1 Million After Releasing DNA Test
    Politics
    Fortune

    Elizabeth Warren Calls on Trump to Pay $1 Million After Releasing DNA Test

    Elizabeth Warren is ready for her pay day. The senator from Massachusetts took to Twitter Monday morning, calling on President Donald Trump to cough up the $1 million he promised if she proved she had Native American heritage.

  • Jamal Khashoggi was accidentally killed during interrogation: report
    World
    Fox Business Videos

    Jamal Khashoggi was accidentally killed during interrogation: report

    Fox Business foreign policy analyst Walid Phares on the report that Saudi journalist Jamal Khashoggi was accidentally killed.

  • Why New Age Beverage Corp. Stock Popped Today
    Business
    Motley Fool

    Why New Age Beverage Corp. Stock Popped Today

    Shares of New Age Beverage Corp. (NASDAQ: NBEV) were climbing again today, riding a surge on marijuana stocks as growers like Tilray, Cronos Group, and Canopy Growth all jumped by double digits. Along with the bullish sentiment in the industry, a number of other factors seemed to be driving New Age shares higher, including the recent hiring of a new CFO, the upcoming legalization of recreational marijuana in Canada on Wednesday, and the market's reaction to its launch last week of a new line of beverages infused with cannabidiol (CBD). On Friday, New Age named Gregory Gould as its new CFO, a notable move as Gould brings experience from the pharmaceutical industry, which should help the beverage company as it moves into CBD products.

  • As Cannabis D-Day Approaches, Winners and Losers Set to Emerge
    Business
    Bloomberg

    As Cannabis D-Day Approaches, Winners and Losers Set to Emerge

    After Canada legalizes recreational marijuana on Oct. 17, it will only take a quarter or two for clear winners and losers to emerge, according to investors and analysts who follow the sector. “These have all been concept stocks and they’re going to actually have to be real companies in another few months, which I think a lot of guys are terrified about,” said Greg Taylor, who manages the Purpose Marijuana Opportunities Fund. Taylor prefers CannTrust Holdings Inc., Hexo Corp. and Organigram Holdings Inc., which he says trade at a “more realistic valuation” than some of their bigger peers.

  • 2 Hot Marijuana Stocks Listing Soon on U.S. Exchanges -- Are They Buys?
    Business
    Motley Fool

    2 Hot Marijuana Stocks Listing Soon on U.S. Exchanges -- Are They Buys?

    Two marijuana stocks that are currently listed on Canadian stock exchanges soon plan also to list on U.S. stock exchanges. Aurora Cannabis (NASDAQOTH: ACBFF) (TSX: ACB) expects to trade on the New York Stock Exchange (NYSE) by the end of October and Aleafia Health (NASDAQOTH: ALEAF) should soon trade on the Nasdaq stock exchange. Are these hot marijuana stocks that are coming soon to U.S. stock exchanges smart picks to buy now?

  • After years of wasting time in meetings, 3 former Googlers decided to do things differently at their new startup
    Business
    Business Insider

    After years of wasting time in meetings, 3 former Googlers decided to do things differently at their new startup

    The executives of the startup Beeswax, all former Google execs, say they've learned how to keep meetings streamlined and efficient. The three founders of the ad-tech startup Beeswax seem to get that. "We're all thoughtful about not having a proliferation of meetings, because one thing we all felt in our previous careers is that there can be lots of redundant meetings," Shamim Samadi, Beeswax's chief product officer, told Business Insider.

  • 3 Reasons 62-Year-Olds Should Take Social Security Now
    Business
    Motley Fool

    3 Reasons 62-Year-Olds Should Take Social Security Now

    As people approach retirement, it's natural to want to claim Social Security as soon as possible. Even though waiting beyond the earliest claiming age of 62 for retirement benefits can give you larger monthly checks, you still have to make it through

  • Saudi Arabia Breaks 45-Year Taboo With Veiled Threat to Use Oil as a Weapon
    World
    Bloomberg

    Saudi Arabia Breaks 45-Year Taboo With Veiled Threat to Use Oil as a Weapon

    While few think that Saudi Arabia is prepared to follow through, even the suggestion of using oil as a weapon undermines Riyadh’s long-standing effort to project itself as a force for economic stability. The anxieties were exacerbated by an opinion piece penned by Turki Al Dakhil, who heads the state-owned Arabiya news network and is close to the Royal Court, in which he openly talked about using oil as a weapon.

  • Goldman Sachs and Raymond James cut Netflix price target ahead of earnings
    Business
    Yahoo Finance Video

    Goldman Sachs and Raymond James cut Netflix price target ahead of earnings

    Netflix getting its price target slashed by both Goldman Sachs and Raymond James ahead of its highly expected earnings report tomorrow. Both firms are concerned that rising interest rates could pinch the company’s valuation.

  • Finance
    TheStreet.com

    Monday Madness: Is Nvidia a Hit or Miss?

    TheStreet's Julie Iannuzzi covered Jim Cramer's investing boot camp. Nvidia (NVDA - Get Report) has long been a favorite of TheStreet's founder and Action Alerts Plus Portfolio Manager Jim Cramer, but he told a packed audience Saturday at his Boot Camp for Investors in New York why his charitable trust recently sold out of the stock.

  • Marijuana stocks to watch: Canopy Growth is the cannabis business’s $4 billion gorilla
    Business
    MarketWatch

    Marijuana stocks to watch: Canopy Growth is the cannabis business’s $4 billion gorilla

    The following article is part of a package of stories that MarketWatch is publishing to mark the start of full legalization of cannabis for adult use in Canada on Wednesday. Smith Falls, Ontario–based Canopy Growth Corp. made headlines and drove cannabis stocks to new heights over the summer when it announced that Corona brewer Constellation Brands Inc. was going to invest an additional $4 billion in the company. Billed by both companies as a strategic partnership, the additional $4 billion investment adds to the 9.9% stake that Constellation bought in October of last year and sets the company up to either be bought outright by Constellation — via warrants that could increase its stake to more than 50% — or continue to work with the beverage company to create a range of consumer-focused cannabis products that may one day appear in markets in dozens of countries.

  • This Is the Average American's Salary. How Does Yours Compare?
    Business
    Motley Fool

    This Is the Average American's Salary. How Does Yours Compare?

    In an age of oversharing, many of us are remarkably tight-lipped when it comes to talking salary. But in reality, knowing where you stand can help you determine whether you're in a good place or whether you should be taking steps to boost your earnings

  • Business
    TheStreet.com

    Canopy Growth Is Poised to Explode to the Upside

    Shares of Canopy have soared 68% over the past three months. In this daily bar chart of CGC, below, we can see that prices are up five-fold over the past 12 months. CGC was trading at $10 back last October and now is trading around $50 with spikes above $55 last month.

  • Business
    InvestorPlace

    Should You Buy Micron Stock on the Dip?

    Micron Technology (NASDAQ:MU), which provides semiconductor systems, has had a difficult time since June. While high volatility in the broader technology market is likely to continue for several more weeks, there are two mildly bearish plays in MU stock that I want to share with you, as each play could lead to impressive profits.

  • Warren Buffett predicted the fall of Eddie Lampert and Sears over 10 years ago (SHLD, BRK.A, BRK.B)
    Finance
    Business Insider

    Warren Buffett predicted the fall of Eddie Lampert and Sears over 10 years ago (SHLD, BRK.A, BRK.B)

    Sears filed for Chapter 11 bankruptcy early Monday, the culmination of a downward spiral. CEO Eddie Lampert, once called the "next Warren Buffett," will also step down. Incidentally, Buffett predicted the retailer's and Lampert's downfall in 2005.

  • Better Marijuana Stock: Aurora Cannabis vs. Auxly Cannabis Group
    Finance
    Motley Fool

    Better Marijuana Stock: Aurora Cannabis vs. Auxly Cannabis Group

    One is market cap: Aurora's market cap is nearly 18 times bigger than Auxly's. Then there's stock performance. Here's how Aurora Cannabis and Auxly Cannabis Group stack up against each other in the areas that do matter.

  • Finance
    TheStreet.com

    General Electric Slips as Cowen Suggests Culp Needs to Take Action

    fell Monday after Cowen and Co. cut its price target on the stock as analysts expect the new Chief Executive Larry Culp to take actions to improve the beleaguered industrial's financial standing. Cowen analysts, including Gautam Khanna, said they expect Culp to impose a dividend cut, possibly raise more equity, and reset earnings per share/free cash flow, to shore up the balance sheet.

  • Finance
    Bloomberg

    Tesla Skeptic Surprised by How Much He Enjoyed the Model 3

    In a broader note about positive electric-car momentum, Jonas said he observed workers at Tesla’s lone auto plant in Fremont, California, who were “extremely busy cranking out Model 3s” for delivery in the U.S. He also drove the dual-motor performance version of the vehicle, which he sees as having better value-for-performance than the Model S sedan. “Frankly, our enjoyment of the high-spec version of the Model 3 took us by surprise,” Jonas said, adding that it’s “hard to say how much this matters.

  • Why Marijuana Stocks Canopy Growth, Cronos Group, and Tilray Crushed It Today
    Business
    Motley Fool

    Why Marijuana Stocks Canopy Growth, Cronos Group, and Tilray Crushed It Today

    The three Canadian marijuana stocks that currently trade on major U.S. stock exchanges enjoyed big gains on Monday. Shares of Canopy Growth (NYSE: CGC) were up 14% as of 3:48 p.m. EDT, while Cronos Group (NASDAQ: CRON) and Tilray (NASDAQ: TLRY) jumped 18.9% and 12.1%, respectively. Two of the three marijuana growers reported new developments earlier in the day.

  • Many U.S. mall owners say good riddance to Sears
    Finance
    Reuters

    Many U.S. mall owners say good riddance to Sears

    The real estate investment trusts that own the malls and shopping centers where many Sears stores are anchor tenants have waited years for the retailer's demise to renovate the sites and boost rent, although redevelopment costs may strain some plans. Most large U.S. malls are controlled by REITs. In recent years, the REITs have cut their exposure to Sears Holdings Corp, which filed for Chapter 11 bankruptcy on Monday.